{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:33:14Z","timestamp":1791343994487,"version":"4.3.1"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2536,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/modpathol.2015.145","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T07:57:51Z","timestamp":1452239871000},"page":"98-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Neoplasms derived from plasmacytoid dendritic cells"],"prefix":"10.1016","volume":"29","author":[{"given":"Fabio","family":"Facchetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cigognetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Fisogni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Lonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Vermi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2015.145_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000205419","article-title":"Karyometrische Untersuchungen an Lymphknotenzellen des Menschen: I. Mitt. Germinoblasten, Lymphoblasten und Lymphozyten","volume":"19","author":"Lennert","year":"1958","journal-title":"Acta Haematol (Basel)"},{"key":"10.1038\/modpathol.2015.145_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/11360","article-title":"Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon","volume":"5","author":"Cella","year":"1999","journal-title":"Nat Med"},{"key":"10.1038\/modpathol.2015.145_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.185.6.1101","article-title":"The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand","volume":"185","author":"Grouard","year":"1997","journal-title":"J Exp Med"},{"key":"10.1038\/modpathol.2015.145_bib4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.imbio.2009.06.013","article-title":"Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage","volume":"214","author":"Vermi","year":"2009","journal-title":"Immunobiology"},{"key":"10.1038\/modpathol.2015.145_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1189\/jlb.0411190","article-title":"Plasmacytoid dendritic cells and cancer","volume":"90","author":"Vermi","year":"2011","journal-title":"J Leukoc Biol"},{"key":"10.1038\/modpathol.2015.145_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.it.2010.05.004","article-title":"Trafficking properties of plasmacytoid dendritic cells in health and disease","volume":"31","author":"Sozzani","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1038\/modpathol.2015.145_bib7","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/ni736","article-title":"Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology","volume":"2","author":"Asselin-Paturel","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1038\/modpathol.2015.145_bib8","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood.V98.13.3520","article-title":"Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice","volume":"98","author":"Bjorck","year":"2001","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.194.8.1171","article-title":"CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells","volume":"194","author":"Nakano","year":"2001","journal-title":"J Exp Med"},{"key":"10.1038\/modpathol.2015.145_bib10","first-page":"849","article-title":"Malignant lymphoma of plasmacytoid T-cells. Morphologic and immunologic studies characterizing a special type of T-cell","volume":"7","author":"Muller-Hermelink","year":"1983","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.145_bib11","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (ed. 4th)","first-page":"145","article-title":"Blastic plasmacytoid dendritic cells neoplasm","author":"Facchetti","year":"2008"},{"key":"10.1038\/modpathol.2015.145_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1141","article-title":"Plasmacytoid dendritic cells in immunity","volume":"5","author":"Colonna","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1038\/modpathol.2015.145_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00428-003-0918-8","article-title":"The plasmacytoid monocyte\/interferon producing cells","volume":"443","author":"Facchetti","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2015.145_bib14","first-page":"15","article-title":"Plasmacytoid T cells. Immunohistochemical evidence for their monocyte\/macrophage origin","volume":"133","author":"Facchetti","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2015.145_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","article-title":"IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors","volume":"23","author":"Liu","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/modpathol.2015.145_bib16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.coviro.2011.10.026","article-title":"Type I interferons: diversity of sources, production pathways and effects on immune responses","volume":"1","author":"Swiecki","year":"2011","journal-title":"Curr Opin Virol"},{"key":"10.1038\/modpathol.2015.145_bib17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.0105-2896.2009.00881.x","article-title":"Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance","volume":"234","author":"Swiecki","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1038\/modpathol.2015.145_bib18","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fimmu.2015.00330","article-title":"Human and mouse mononuclear phagocyte networks: a tale of two species?","volume":"6","author":"Reynolds","year":"2015","journal-title":"Front Immunol"},{"key":"10.1038\/modpathol.2015.145_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/79747","article-title":"Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent Th1 polarization","volume":"1","author":"Cella","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1038\/modpathol.2015.145_bib20","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/eji.200636026","article-title":"From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation","volume":"36","author":"Soumelis","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1038\/modpathol.2015.145_bib21","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.4049\/jimmunol.1000454","article-title":"Plasmacytoid dendritic cell dichotomy: identification of IFN-alpha producing cells as a phenotypically and functionally distinct subset","volume":"186","author":"Bjorck","year":"2011","journal-title":"J Immunol"},{"key":"10.1038\/modpathol.2015.145_bib22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.immuni.2011.10.014","article-title":"Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo","volume":"35","author":"Takagi","year":"2011","journal-title":"Immunity"},{"key":"10.1038\/modpathol.2015.145_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-immunol-031210-101345","article-title":"Plasmacytoid dendritic cells: recent progress and open questions","volume":"29","author":"Reizis","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1038\/modpathol.2015.145_bib24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1684\/ejd.2010.0816","article-title":"Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer","volume":"20","author":"Charles","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1038\/modpathol.2015.145_bib25","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood.V96.3.878","article-title":"In vivo generation of human dendritic cell subsets by Flt3 ligand","volume":"96","author":"Maraskovsky","year":"2000","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.20030323","article-title":"Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo","volume":"198","author":"Karsunky","year":"2003","journal-title":"J Exp Med"},{"key":"10.1038\/modpathol.2015.145_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2008.09.016","article-title":"Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development","volume":"135","author":"Cisse","year":"2008","journal-title":"Cell"},{"key":"10.1038\/modpathol.2015.145_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1084\/jem.20141442","article-title":"Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow","volume":"212","author":"Lee","year":"2015","journal-title":"J Exp Med"},{"key":"10.1038\/modpathol.2015.145_bib29","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2010.11.020","article-title":"Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual","volume":"33","author":"Swiecki","year":"2010","journal-title":"Immunity"},{"key":"10.1038\/modpathol.2015.145_bib30","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20132620","article-title":"Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model","volume":"211","author":"Rowland","year":"2014","journal-title":"J Exp Med"},{"key":"10.1038\/modpathol.2015.145_bib31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.humimm.2009.07.005","article-title":"Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood","volume":"70","author":"Jing","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1038\/modpathol.2015.145_bib32","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.165.11.6037","article-title":"BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood","volume":"165","author":"Dzionek","year":"2000","journal-title":"J Immunol"},{"key":"10.1038\/modpathol.2015.145_bib33","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.194.12.1823","article-title":"BDCA-2, a novel plasmacytoid dendritic cell cell-specific type II C-type lectin, mediates antigen-capture and is a potent inhibitor of interferon-alpha\/beta induction","volume":"194","author":"Dzionek","year":"2001","journal-title":"J Exp Med"},{"key":"10.1038\/modpathol.2015.145_bib34","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/00000478-200207000-00003","article-title":"\u2018Agranular CD4+ CD56+ hematodermic neoplasm\u2019 (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes","volume":"26","author":"Petrella","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.145_bib35","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0046-8177(88)80091-1","article-title":"Plasmacytoid T cells: a cell population normally present in the reactive lymph node. An immunohistochemical and electronmicroscopic study","volume":"19","author":"Facchetti","year":"1988","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.145_bib36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/PAP.0b013e3181bb6bc2","article-title":"Plasmacytoid dendritic cells: physiologic roles and pathologic states","volume":"16","author":"Jegalian","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"10.1038\/modpathol.2015.145_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02889173","article-title":"Pseudofollikul\u00e4re Nester von Plasmazellen (eines besonderen Typs?)in der paracorticalen Pulpa menschlicher Lymphknoten","volume":"14","author":"M\u00fcller-Hermelink","year":"1973","journal-title":"Virchows Arch (Cell Pathol)"},{"key":"10.1038\/modpathol.2015.145_bib38","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2013-05-500413","article-title":"BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells","volume":"122","author":"Boiocchi","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib39","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1182\/blood-2002-10-3297","article-title":"TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin","volume":"101","author":"Herling","year":"2003","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib40","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1097\/00000478-200311000-00015","article-title":"Neoplasms derived from plasmacytoid monocytes\/interferon-producing cells: variability of CD56 and granzyme B expression","volume":"27","author":"Facchetti","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.145_bib41","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1182\/blood-2007-10-117531","article-title":"Novel markers of normal and neoplastic human plasmacytoid dendritic cells","volume":"111","author":"Marafioti","year":"2008","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib42","first-page":"941","article-title":"CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells","volume":"88","author":"Jacob","year":"2003","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2015.145_bib43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00000478-200405000-00004","article-title":"Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders","volume":"28","author":"Vermi","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.145_bib44","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1309\/UNM9TY9QJQNFFYTH","article-title":"Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia","volume":"120","author":"Chen","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.145_bib45","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/PAS.0b013e31825dd4de","article-title":"Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases","volume":"36","author":"Vitte","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.145_bib46","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1309\/AJCPFMNYCVPDEND0","article-title":"Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases","volume":"135","author":"Benet","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.145_bib47","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.145_bib48","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/modpathol.3800707","article-title":"Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology","volume":"19","author":"Orazi","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.145_bib49","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1600-0560.2011.01777.x","article-title":"Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm","volume":"38","author":"Dargent","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1038\/modpathol.2015.145_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00000478-199101000-00011","article-title":"Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization","volume":"15","author":"Harris","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.145_bib51","doi-asserted-by":"crossref","unstructured":"Dargent JL, Henne S, Pranger D et al. Tumor-forming plasmacytoid dendritic cells associated with myeloid neoplasms. Report of a peculiar case with histopathologic features masquerading as lupus erythematosus. J Cutan Pathol 2015.","DOI":"10.1111\/cup.12639"},{"key":"10.1038\/modpathol.2015.145_bib52","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1002\/1097-0142(19950515)75:10<2474::AID-CNCR2820751013>3.0.CO;2-Y","article-title":"Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents","volume":"75","author":"Brody","year":"1995","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.145_bib53","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00000478-199710000-00014","article-title":"Blastic natural killer cell leukemia\/lymphoma: a clinicopathologic study","volume":"21","author":"DiGiuseppe","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.145_bib54","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1309\/FY6PK436NBK0RYD4","article-title":"CD4+\/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells","volume":"127","author":"Herling","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.145_bib55","series-title":"Tumours of Haematopoietic and Lymphoid Tissues","first-page":"214","article-title":"Blastic NK-cell lymphoma","author":"Chan","year":"2001"},{"key":"10.1038\/modpathol.2015.145_bib56","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-131-7-199910050-00035","article-title":"CD123hi dendritic cell lymphoma: an unusual case of non-Hodgkin lymphoma","volume":"131","author":"Lucio","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1038\/modpathol.2015.145_bib57","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood.V97.10.3210","article-title":"Identification of a leukemic counterpart of the plasmacytoid dendritic cells","volume":"97","author":"Chaperot","year":"2001","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib58","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/eji.200324531","article-title":"Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts","volume":"34","author":"Chaperot","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1038\/modpathol.2015.145_bib59","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1309\/0QPPAVTUPCV9UCLV","article-title":"TCL1 and CLA expression in agranular CD4\/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis","volume":"122","author":"Petrella","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.145_bib60","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.humpath.2005.07.002","article-title":"CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype","volume":"36","author":"Urosevic","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1038\/modpathol.2015.145_bib61","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0609.2005.00513.x","article-title":"Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells","volume":"75","author":"Gopcsa","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1038\/modpathol.2015.145_bib62","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/01.pas.0000172194.32918.5c","article-title":"CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells","volume":"29","author":"Reichard","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.145_bib63","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/modpathol.3800679","article-title":"Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms","volume":"19","author":"Jaye","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2015.145_bib64","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1309\/W9Q5AGYDE5LANN39","article-title":"CD4+\/CD56+ hematodermic neoplasm ('blastic natural killer cell lymphoma'): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon","volume":"128","author":"Pilichowska","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.145_bib65","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1182\/blood-2010-11-319699","article-title":"BAD-LAMP is a novel biomarker of nonactivated human plasmacytoid dendritic cells","volume":"118","author":"Defays","year":"2011","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib66","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood-2006-04-018143","article-title":"Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities","volume":"109","author":"Dijkman","year":"2007","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib67","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/sj.leu.2403452","article-title":"In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response","volume":"18","author":"Bendriss-Vermare","year":"2004","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.145_bib68","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1532\/IJH97.04116","article-title":"A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma","volume":"81","author":"Maeda","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1038\/modpathol.2015.145_bib69","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.leukres.2010.03.002","article-title":"Transformation of dendritic cells from plasmacytoid to myeloid in a leukemic plasmacytoid dendritic cell line (PMDC05)","volume":"34","author":"Watanabe","year":"2010","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2015.145_bib70","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.leukres.2009.03.047","article-title":"A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-alpha by stimulation via Toll-like receptors and present antigens to naive T cells","volume":"33","author":"Narita","year":"2009","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2015.145_bib71","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1309\/GJWNPD8HU5MAJ837","article-title":"Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review","volume":"123","author":"Petrella","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2015.145_bib72","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/cncr.21268","article-title":"Blastic natural killer cell lymphoma\/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement","volume":"104","author":"Suzuki","year":"2005","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.145_bib73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00000478-199902000-00001","article-title":"CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity?","volume":"23","author":"Petrella","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.145_bib74","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/jcp.2006.042135","article-title":"CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer","volume":"60","author":"Assaf","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2015.145_bib75","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/annonc\/mdh268","article-title":"CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature","volume":"15","author":"Bekkenk","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1038\/modpathol.2015.145_bib76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0b013e3181c5e26b","article-title":"Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients","volume":"34","author":"Cota","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.145_bib77","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/bjd.12412","article-title":"Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients","volume":"169","author":"Julia","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1038\/modpathol.2015.145_bib78","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/his.12079","article-title":"Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm","volume":"62","author":"Hwang","year":"2013","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2015.145_bib79","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood.V99.5.1556","article-title":"Clinical and biologic features of CD4(+)CD56(+) malignancies","volume":"99","author":"Feuillard","year":"2002","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib80","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2133.2009.09373.x","article-title":"Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?","volume":"162","author":"Dalle","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1038\/modpathol.2015.145_bib81","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.leukres.2009.09.006","article-title":"Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group","volume":"34","author":"Tsagarakis","year":"2010","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2015.145_bib82","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.leukres.2011.07.033","article-title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review","volume":"36","author":"Rauh","year":"2012","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2015.145_bib83","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3324\/haematol.2012.072645","article-title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study","volume":"98","author":"Pagano","year":"2013","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2015.145_bib84","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00277-014-2193-y","article-title":"Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation-a single center experience","volume":"94","author":"Heinicke","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1038\/modpathol.2015.145_bib85","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/cncr.10489","article-title":"CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia","volume":"94","author":"Khoury","year":"2002","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2015.145_bib86","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1365-2133.2003.05639.x","article-title":"Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more?","volume":"149","author":"Kazakov","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1038\/modpathol.2015.145_bib87","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/PAS.0000000000000156","article-title":"Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients","volume":"38","author":"Julia","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.145_bib88","first-page":"ELT10","article-title":"The CD4+ CD56+ CD116- CD123+ CD45RA+ CD45RO- profile is specific of DC2 malignancies","volume":"88","author":"Trimoreau","year":"2003","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2015.145_bib89","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.pas.0000126719.71954.4f","article-title":"Subcutaneous, blastic natural killer (NK), NK\/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients","volume":"28","author":"Massone","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2015.145_bib90","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3324\/haematol.2010.026179","article-title":"Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications","volume":"95","author":"Jegalian","year":"2010","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2015.145_bib91","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ajh.23567","article-title":"TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow","volume":"88","author":"Alayed","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1038\/modpathol.2015.145_bib92","doi-asserted-by":"crossref","first-page":"19204","DOI":"10.18632\/oncotarget.4146","article-title":"Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile","volume":"6","author":"Martin-Martin","year":"2015","journal-title":"Oncotarget"},{"key":"10.1038\/modpathol.2015.145_bib93","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2141.2009.07679.x","article-title":"Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia","volume":"145","author":"Garnache-Ottou","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2015.145_bib94","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1182\/blood.V99.11.4154","article-title":"CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique","volume":"99","author":"Leroux","year":"2002","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib95","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/jid.2009.369","article-title":"Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms","volume":"130","author":"Wiesner","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/modpathol.2015.145_bib96","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1182\/blood-2011-03-337501","article-title":"Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion","volume":"118","author":"Lucioni","year":"2011","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib97","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2141.2010.08556.x","article-title":"TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm","volume":"153","author":"Jardin","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2015.145_bib98","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.18632\/oncotarget.2223","article-title":"Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm","volume":"5","author":"Stenzinger","year":"2014","journal-title":"Oncotarget"},{"key":"10.1038\/modpathol.2015.145_bib99","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/leu.2013.283","article-title":"Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm","volume":"28","author":"Menezes","year":"2014","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.145_bib100","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/leu.2014.64","article-title":"Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition","volume":"28","author":"Sapienza","year":"2014","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2015.145_bib101","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.bmt.1704215","article-title":"What is CD4+CD56+ malignancy and how should it be treated?","volume":"32","author":"Reimer","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1038\/modpathol.2015.145_bib102","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2012-08-448613","article-title":"Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation","volume":"121","author":"Roos-Weil","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib103","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bbmt.2010.12.706","article-title":"Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity","volume":"17","author":"Dietrich","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1038\/modpathol.2015.145_bib104","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood-2015-01-621268","article-title":"Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm","volume":"125","author":"Aoki","year":"2015","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1182\/blood-2014-04-566737","article-title":"Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients","volume":"124","author":"Frankel","year":"2014","journal-title":"Blood"},{"key":"10.1038\/modpathol.2015.145_bib106","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3324\/haematol.2014.111740","article-title":"In vivoin vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent","volume":"100","author":"Angelot-Delettre","year":"2015","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2015.145_bib107","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/ejh.12294","article-title":"Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-azacytidine","volume":"93","author":"Laribi","year":"2014","journal-title":"Eur J Haematol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2015145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2015145","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222013011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222013011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2015145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:48:05Z","timestamp":1760230085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222013011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0893395222013011"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2015.145","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoplasms derived from plasmacytoid dendritic cells","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2015.145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}